The stock of Inmode Ltd (INMD) has gone down by -1.20% for the week, with a 12.56% rise in the past month and a 18.75% rise in the past quarter. The volatility ratio for the week is 2.48%, and the volatility levels for the past 30 days are 3.12% for INMD. The simple moving average for the past 20 days is 3.96% for INMD’s stock, with a 2.55% simple moving average for the past 200 days.
Is It Worth Investing in Inmode Ltd (NASDAQ: INMD) Right Now?
The price-to-earnings ratio for Inmode Ltd (NASDAQ: INMD) is 10.27x, which is above its average ratio. Moreover, the 36-month beta value for INMD is 2.08. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 4 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for INMD is 75.25M and currently, short sellers hold a 8.28% of that float. On November 15, 2024, INMD’s average trading volume was 1.13M shares.
INMD) stock’s latest price update
The stock of Inmode Ltd (NASDAQ: INMD) has decreased by -1.66 when compared to last closing price of 19.32. Despite this, the company has experienced a -1.20% fall in its stock price over the last five trading sessions. prnewswire.com reported 2024-11-06 that YOKNEAM, Israel, Nov. 6, 2024 /PRNewswire/ — InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in November and December: UBS Global Healthcare Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Danielle Antalffy, Senior Equity Analyst, and one-on-one meetings Location: Palos Verdes, CA When: Tuesday, Nov. 12 at 2:00 pm PT A live webcast of the presentation can be accessed here.
Analysts’ Opinion of INMD
Many brokerage firms have already submitted their reports for INMD stocks, with BTIG Research repeating the rating for INMD by listing it as a “Buy.” The predicted price for INMD in the upcoming period, according to BTIG Research is $25 based on the research report published on October 17, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see INMD reach a price target of $19, previously predicting the price at $21. The rating they have provided for INMD stocks is “Hold” according to the report published on July 23rd, 2024.
UBS gave a rating of “Neutral” to INMD, setting the target price at $24 in the report published on November 03rd of the previous year.
INMD Trading at 10.54% from the 50-Day Moving Average
After a stumble in the market that brought INMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.10% of loss for the given period.
Volatility was left at 3.12%, however, over the last 30 days, the volatility rate increased by 2.48%, as shares surge +10.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +21.41% upper at present.
During the last 5 trading sessions, INMD fell by -1.20%, which changed the moving average for the period of 200-days by -19.80% in comparison to the 20-day moving average, which settled at $18.28. In addition, Inmode Ltd saw -14.57% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for INMD
Current profitability levels for the company are sitting at:
- 0.32 for the present operating margin
- 0.82 for the gross margin
The net margin for Inmode Ltd stands at 0.36. The total capital return value is set at 0.18. Equity return is now at value 21.04, with 19.00 for asset returns.
Currently, EBITDA for the company is 196.28 million with net debt to EBITDA at -1.09. When we switch over and look at the enterprise to sales, we see a ratio of 3.42. The receivables turnover for the company is 6.5for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.68.
Conclusion
To wrap up, the performance of Inmode Ltd (INMD) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
